Howard DH, Maiers M., Kollman C., Logan B., Gragert L., Setterholm M.A cost-benefit analysis of increasing cord blood inventory levels. In: Committee on Establishing a National Cord Blood Stem Cell Bank Program.Meyer EA, Hanna K, Gebbie K, eds. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington (DC): National Academies Press; 2005. p 221-41.
2.
Howard DH, Meltzer D., Kollman C., et al. Use of Cost-Effectiveness Analysis to Determine Inventory Size for a National Cord Blood Bank. Med Decis Making. 2008;28:243-53.
3.
Neumann PJUsing Cost-EffectivenessAnalysis to Improve Health Care: Opportunities and Barriers. New York: Oxford University Press; 2004.
4.
Berger MLThe once and future application of cost-effectiveness analysis. Jt Comm J Qual Improv. 1999;25(9): 455-61.
5.
Neumann PJ, Rosen AB, Weinstein MCMedicare and cost-effectiveness analysis. N Engl J Med. 2005;353:1516.
6.
Gold MR, Sofaer S., Siegelberg T.Medicare and cost-effectiveness analysis: time to ask the taxpayers. Health Affairs. 2007;26(5): 1399-406.
7.
Gold MR, Franks P., Siegelberg T., Sofaer S.Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers? Health Policy. 2007;83(1): 65-72.
8.
Cline RR, Gupta K.Drug benefit decisions among older adults: a policy-capturing analysis. Med Decis Making. 2006;26: 273-81.
9.
Lomas J., Culyer T., McCutcheon C., McAuley L., Law S., for the Canadian Health Services Research Foundation.Conceptualizing and Combining Evidence for Health System Guidance. May 2005. Canadian Health Services Research Foundation . Available at: http://www.chsrf.ca/other_documents/pdf/evidence_e.pdf . Accessed February 6, 2008.
10.
Canadian Health ServicesResearch Foundation.How to be a good research partner. A guide for health-system managers and policy makers. Available at: http://www.chsrf.ca/other_ documents/pdf/partner_e.pdf. Accessed February 6, 2008.
